Review



anti cd9 polyclonal primary antibodies  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bioss anti cd9 polyclonal primary antibodies
    Anti Cd9 Polyclonal Primary Antibodies, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd9 polyclonal primary antibodies/product/Bioss
    Average 94 stars, based on 4 article reviews
    anti cd9 polyclonal primary antibodies - by Bioz Stars, 2026-04
    94/100 stars

    Images



    Similar Products

    94
    Bioss anti cd9 polyclonal primary antibodies
    Anti Cd9 Polyclonal Primary Antibodies, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd9 polyclonal primary antibodies/product/Bioss
    Average 94 stars, based on 1 article reviews
    anti cd9 polyclonal primary antibodies - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    96
    Proteintech anti cd9 primary antibody
    nsPEFs enhanced the release of EVs from MSCs and EVs-nsPEFs enhanced viability, proliferation and migration of chondrocytes and reversed the change of cartilage markers in OA-like chondrocytes. (A) Morphology of EVs and EVs-nsPEFs under TEM. Scale bars, 200 nm. (B) The number of EVs in random field (n = 6) was counted. (C) EVs size distributions and particle concentration analyzed by NTA. (D) Analysis changes of particle concentration between EVs and EVs-nsPEFs. (E) Analysis changes of the protein concentration between EVs and EVs-nsPEFs using BCA method. (F) WB results for the EVs markers <t>CD9,</t> Alix, TSG101 and the negative marker Calnexin. (G) Representative bioluminescence images for Red dye Dil-labeled EVs and EVs-nsPEFs in chondrocytes at 6 h, 12 h and 24 h. Scale bars, 50 μm. (H) CCK8 assay to determine the viability of chondrocytes co-cultured with EVs and EVs-nsPEFs (n = 6). (I) Representative images of EDU staining of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 200 μm. (J) Representative images of transwell migration assay of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 100 μm. (K) Quantitative analysis of positive cells by EDU staining (n = 4). (L) Quantitative analysis of migrated cells by transwell assay (n = 4). (M) Schematic diagram of experimental design. (N) Representative images of immunofluorescence assay to detect the expression of Collagen II and MMP13 in chondrocytes in control (Group Normal), OA-like chondrocytes (Group IL-1β), OA-like chondrocytes co-cultured with EVs (Group EVs) or EVs-nsPEFs (Group EVs-nsPEFs). Scale bars, 50 μm. Quantitative analysis of immunofluorescence assay to detect the expression of (O) Collagen II and (P) MMP13 in chondrocytes (n = 4). * P < 0.05, ** P < 0.01, **** P < 0.0001. Bar labeled with different lowercase letters indicate a significant difference.
    Anti Cd9 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd9 primary antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    anti cd9 primary antibody - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    90
    System Biosciences Inc polyclonal rabbit anti-cd9 primary antibody
    nsPEFs enhanced the release of EVs from MSCs and EVs-nsPEFs enhanced viability, proliferation and migration of chondrocytes and reversed the change of cartilage markers in OA-like chondrocytes. (A) Morphology of EVs and EVs-nsPEFs under TEM. Scale bars, 200 nm. (B) The number of EVs in random field (n = 6) was counted. (C) EVs size distributions and particle concentration analyzed by NTA. (D) Analysis changes of particle concentration between EVs and EVs-nsPEFs. (E) Analysis changes of the protein concentration between EVs and EVs-nsPEFs using BCA method. (F) WB results for the EVs markers <t>CD9,</t> Alix, TSG101 and the negative marker Calnexin. (G) Representative bioluminescence images for Red dye Dil-labeled EVs and EVs-nsPEFs in chondrocytes at 6 h, 12 h and 24 h. Scale bars, 50 μm. (H) CCK8 assay to determine the viability of chondrocytes co-cultured with EVs and EVs-nsPEFs (n = 6). (I) Representative images of EDU staining of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 200 μm. (J) Representative images of transwell migration assay of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 100 μm. (K) Quantitative analysis of positive cells by EDU staining (n = 4). (L) Quantitative analysis of migrated cells by transwell assay (n = 4). (M) Schematic diagram of experimental design. (N) Representative images of immunofluorescence assay to detect the expression of Collagen II and MMP13 in chondrocytes in control (Group Normal), OA-like chondrocytes (Group IL-1β), OA-like chondrocytes co-cultured with EVs (Group EVs) or EVs-nsPEFs (Group EVs-nsPEFs). Scale bars, 50 μm. Quantitative analysis of immunofluorescence assay to detect the expression of (O) Collagen II and (P) MMP13 in chondrocytes (n = 4). * P < 0.05, ** P < 0.01, **** P < 0.0001. Bar labeled with different lowercase letters indicate a significant difference.
    Polyclonal Rabbit Anti Cd9 Primary Antibody, supplied by System Biosciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti-cd9 primary antibody/product/System Biosciences Inc
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-cd9 primary antibody - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    86
    Danaher Inc rabbit polyclonal primary antibodies anti cd9
    nsPEFs enhanced the release of EVs from MSCs and EVs-nsPEFs enhanced viability, proliferation and migration of chondrocytes and reversed the change of cartilage markers in OA-like chondrocytes. (A) Morphology of EVs and EVs-nsPEFs under TEM. Scale bars, 200 nm. (B) The number of EVs in random field (n = 6) was counted. (C) EVs size distributions and particle concentration analyzed by NTA. (D) Analysis changes of particle concentration between EVs and EVs-nsPEFs. (E) Analysis changes of the protein concentration between EVs and EVs-nsPEFs using BCA method. (F) WB results for the EVs markers <t>CD9,</t> Alix, TSG101 and the negative marker Calnexin. (G) Representative bioluminescence images for Red dye Dil-labeled EVs and EVs-nsPEFs in chondrocytes at 6 h, 12 h and 24 h. Scale bars, 50 μm. (H) CCK8 assay to determine the viability of chondrocytes co-cultured with EVs and EVs-nsPEFs (n = 6). (I) Representative images of EDU staining of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 200 μm. (J) Representative images of transwell migration assay of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 100 μm. (K) Quantitative analysis of positive cells by EDU staining (n = 4). (L) Quantitative analysis of migrated cells by transwell assay (n = 4). (M) Schematic diagram of experimental design. (N) Representative images of immunofluorescence assay to detect the expression of Collagen II and MMP13 in chondrocytes in control (Group Normal), OA-like chondrocytes (Group IL-1β), OA-like chondrocytes co-cultured with EVs (Group EVs) or EVs-nsPEFs (Group EVs-nsPEFs). Scale bars, 50 μm. Quantitative analysis of immunofluorescence assay to detect the expression of (O) Collagen II and (P) MMP13 in chondrocytes (n = 4). * P < 0.05, ** P < 0.01, **** P < 0.0001. Bar labeled with different lowercase letters indicate a significant difference.
    Rabbit Polyclonal Primary Antibodies Anti Cd9, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal primary antibodies anti cd9/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    rabbit polyclonal primary antibodies anti cd9 - by Bioz Stars, 2026-04
    86/100 stars
      Buy from Supplier

    94
    Bioss primary antibodies foe anti cd9
    nsPEFs enhanced the release of EVs from MSCs and EVs-nsPEFs enhanced viability, proliferation and migration of chondrocytes and reversed the change of cartilage markers in OA-like chondrocytes. (A) Morphology of EVs and EVs-nsPEFs under TEM. Scale bars, 200 nm. (B) The number of EVs in random field (n = 6) was counted. (C) EVs size distributions and particle concentration analyzed by NTA. (D) Analysis changes of particle concentration between EVs and EVs-nsPEFs. (E) Analysis changes of the protein concentration between EVs and EVs-nsPEFs using BCA method. (F) WB results for the EVs markers <t>CD9,</t> Alix, TSG101 and the negative marker Calnexin. (G) Representative bioluminescence images for Red dye Dil-labeled EVs and EVs-nsPEFs in chondrocytes at 6 h, 12 h and 24 h. Scale bars, 50 μm. (H) CCK8 assay to determine the viability of chondrocytes co-cultured with EVs and EVs-nsPEFs (n = 6). (I) Representative images of EDU staining of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 200 μm. (J) Representative images of transwell migration assay of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 100 μm. (K) Quantitative analysis of positive cells by EDU staining (n = 4). (L) Quantitative analysis of migrated cells by transwell assay (n = 4). (M) Schematic diagram of experimental design. (N) Representative images of immunofluorescence assay to detect the expression of Collagen II and MMP13 in chondrocytes in control (Group Normal), OA-like chondrocytes (Group IL-1β), OA-like chondrocytes co-cultured with EVs (Group EVs) or EVs-nsPEFs (Group EVs-nsPEFs). Scale bars, 50 μm. Quantitative analysis of immunofluorescence assay to detect the expression of (O) Collagen II and (P) MMP13 in chondrocytes (n = 4). * P < 0.05, ** P < 0.01, **** P < 0.0001. Bar labeled with different lowercase letters indicate a significant difference.
    Primary Antibodies Foe Anti Cd9, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies foe anti cd9/product/Bioss
    Average 94 stars, based on 1 article reviews
    primary antibodies foe anti cd9 - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    Image Search Results


    nsPEFs enhanced the release of EVs from MSCs and EVs-nsPEFs enhanced viability, proliferation and migration of chondrocytes and reversed the change of cartilage markers in OA-like chondrocytes. (A) Morphology of EVs and EVs-nsPEFs under TEM. Scale bars, 200 nm. (B) The number of EVs in random field (n = 6) was counted. (C) EVs size distributions and particle concentration analyzed by NTA. (D) Analysis changes of particle concentration between EVs and EVs-nsPEFs. (E) Analysis changes of the protein concentration between EVs and EVs-nsPEFs using BCA method. (F) WB results for the EVs markers CD9, Alix, TSG101 and the negative marker Calnexin. (G) Representative bioluminescence images for Red dye Dil-labeled EVs and EVs-nsPEFs in chondrocytes at 6 h, 12 h and 24 h. Scale bars, 50 μm. (H) CCK8 assay to determine the viability of chondrocytes co-cultured with EVs and EVs-nsPEFs (n = 6). (I) Representative images of EDU staining of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 200 μm. (J) Representative images of transwell migration assay of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 100 μm. (K) Quantitative analysis of positive cells by EDU staining (n = 4). (L) Quantitative analysis of migrated cells by transwell assay (n = 4). (M) Schematic diagram of experimental design. (N) Representative images of immunofluorescence assay to detect the expression of Collagen II and MMP13 in chondrocytes in control (Group Normal), OA-like chondrocytes (Group IL-1β), OA-like chondrocytes co-cultured with EVs (Group EVs) or EVs-nsPEFs (Group EVs-nsPEFs). Scale bars, 50 μm. Quantitative analysis of immunofluorescence assay to detect the expression of (O) Collagen II and (P) MMP13 in chondrocytes (n = 4). * P < 0.05, ** P < 0.01, **** P < 0.0001. Bar labeled with different lowercase letters indicate a significant difference.

    Journal: Journal of Orthopaedic Translation

    Article Title: Functionally improved mesenchymal stem cells via nanosecond pulsed electric fields for better treatment of osteoarthritis

    doi: 10.1016/j.jot.2024.03.006

    Figure Lengend Snippet: nsPEFs enhanced the release of EVs from MSCs and EVs-nsPEFs enhanced viability, proliferation and migration of chondrocytes and reversed the change of cartilage markers in OA-like chondrocytes. (A) Morphology of EVs and EVs-nsPEFs under TEM. Scale bars, 200 nm. (B) The number of EVs in random field (n = 6) was counted. (C) EVs size distributions and particle concentration analyzed by NTA. (D) Analysis changes of particle concentration between EVs and EVs-nsPEFs. (E) Analysis changes of the protein concentration between EVs and EVs-nsPEFs using BCA method. (F) WB results for the EVs markers CD9, Alix, TSG101 and the negative marker Calnexin. (G) Representative bioluminescence images for Red dye Dil-labeled EVs and EVs-nsPEFs in chondrocytes at 6 h, 12 h and 24 h. Scale bars, 50 μm. (H) CCK8 assay to determine the viability of chondrocytes co-cultured with EVs and EVs-nsPEFs (n = 6). (I) Representative images of EDU staining of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 200 μm. (J) Representative images of transwell migration assay of chondrocytes co-cultured with EVs and EVs-nsPEFs. Scale bars, 100 μm. (K) Quantitative analysis of positive cells by EDU staining (n = 4). (L) Quantitative analysis of migrated cells by transwell assay (n = 4). (M) Schematic diagram of experimental design. (N) Representative images of immunofluorescence assay to detect the expression of Collagen II and MMP13 in chondrocytes in control (Group Normal), OA-like chondrocytes (Group IL-1β), OA-like chondrocytes co-cultured with EVs (Group EVs) or EVs-nsPEFs (Group EVs-nsPEFs). Scale bars, 50 μm. Quantitative analysis of immunofluorescence assay to detect the expression of (O) Collagen II and (P) MMP13 in chondrocytes (n = 4). * P < 0.05, ** P < 0.01, **** P < 0.0001. Bar labeled with different lowercase letters indicate a significant difference.

    Article Snippet: After blocking with 5% bovine serum albumin (BSA) blocking solution for 1 h at room temperature, membranes were incubated with anti-CD9 primary antibody (1: 1000; Affinity, AF5139, China), ALIX (1: 2000; Proteintech, 12422-1 -AP, USA), TSG101 (1:500; Affinity, DF8427, China) and Calnexin (1:1000; Affinity, AF5362, China) at 4 °C overnight, respectively.

    Techniques: Migration, Concentration Assay, Protein Concentration, Marker, Labeling, CCK-8 Assay, Cell Culture, Staining, Transwell Migration Assay, Transwell Assay, Immunofluorescence, Expressing, Control